← Home
The Twenty Minute VC · July 18, 2026 · 1h 27m
$5BN in Revenue, 7 to 7,000 Employees in 9 Months, 206,000 Tests in a Single Day: The Craziest Story in Startups: Curative with Fred Turner
Fred Turner, founder and CEO of Curative, discusses one of the most explosive growth stories in startup history: scaling a COVID testing business from zero to $5 billion in revenue in nine months, growing from 7 to 7,000 employees, and processing over 206,000 tests daily. The conversation spans Curative's pivot into health insurance, the role of AI in restructuring the business, and Turner's views on the future of work, healthcare incumbents, and nuclear energy.
This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.
Curious
•
Fred argues SaaS is dead, evidenced by Curative cutting 80% of software spend—suggesting AI is making traditional software tools obsolete faster than most companies realize.
Novel
Highlights
•
•
Legacy health insurers are vulnerable to AI-native insurgents because their cost structure and decision-making processes can't adapt fast enough to compete with companies building efficiency into DNA.
Editorial
•
Pivoting a Hypergrowth Business Into a New Market Requires Belief in the Bigger Problem36:00
Fred chose to pivot Curative from COVID testing (a temporary $5B business) into health insurance because he saw healthcare's fundamental brokenness as a bigger problem than pandemic testing.Misc
✧Curative scaled to 206,000 COVID tests per day at peak—logistical scale comparable to small countries.
✧Fred transitioned Curative from testing into health insurance to attack the broken healthcare system directly.
✧Curative is cutting 80% of software spend—suggests major SaaS category disruption ahead.
✧Turner believes AI will make companies structurally smaller by compressing labor needs.
✧Fred is investing in subcritical nuclear as a potential business larger than Curative itself.
Was this useful?